Introduction {#Sec1}
============

Mutations in the LMNA gene are the causal agent for a subset of genetic diseases affecting mesoderm tissues called laminopathies \[[@CR1]\]. Among these, Hutchinson-Gilford Progeria Syndrome (HGPS) or progeria \[[@CR2]--[@CR4]\] is a fatal disease with a very low incidence characterized by a typical clinical picture of older pathologies \[[@CR5]\]. HGPS-affected patients begin to show symptoms of accelerated aging at the age of 2, and typically die at an average age of 13 years, usually due to cardiovascular deficiencies. HGPS is due, in most cases, to the point mutation G608G in the LMNA gene encoding Lamins A and C, major structural components of the nuclear lamina \[[@CR6], [@CR7]\]. Although historically thought to be involved only in nuclear structure, roles in replication, chromatin organization and stem cell differentiation have been demonstrated recently for Lamin A \[[@CR8], [@CR9]\]. It is also proposed that Lamin A has a role in reorganization of replication and chromatin \[[@CR10]\]. Lamin A is initially produced as a precursor, pre-Lamin A, farnesylated at its C-terminus, and processed by the protease Zmpste24/FACE-1 that removes the farnesylated part. In HGPS, the mutation causes the occurrence of a cryptic alternative processing site, generating a truncated isoform, progerin (PG), lacking the recognition site for Zmpste24/FACE-1. Farnesylated PG does not properly process, accumulates in the nuclear envelope, causes structural defects in the nuclear lamina and may be interfering with regulation of the signalling pathway mediated by p16/Rb necessary to maintain the balance between differentiation and proliferation of stem cells in the tissue regeneration process \[[@CR8]\]. Finally, several studies showed the importance of accumulation of the farnesylated precursor in the development of the disease \[[@CR11]--[@CR13]\].

The main function of adipose tissue is to store and manage excess energy in the form of triglycerides and to facilitate the liberation and lipolysis in periods of nutritional deficiency or energy demand \[[@CR14]\]. The balance between lipid storage and lipolysis is controlled by neuroendocrine signals \[[@CR15], [@CR16]\] in response to the nutritional status of the organism. The hypothalamus has been proposed as the central coordinator of this process, integrating the action of circulating hormones and nutrients \[[@CR17]\]. In human lipodystrophies, insulin resistance and loss of regenerative potential in the adipose tissue are the main landmarks \[[@CR18]\] leading to complications in normal aging and disease. Also, an extremely accelerated lipodystrophia occurs in progeroid syndromes, such as HGPS and other laminopathies \[[@CR19], [@CR20]\].

Our purpose for this study was to unravel the underlying mechanism of PG-driven lipodystrophy using quantitative shotgun proteomics (isobaric tags for relative quantification (iTRAQ)) and to determine the molecular pathways modulated by the lentiviral expression of this aberrant form of Lamin A in the 3T3L1 pre-adipocyte cell line, one of the most studied models of adipogenic differentiation \[[@CR21], [@CR22]\].

Methods {#Sec2}
=======

Culture of mouse 3T3L1 pre-adipocytes {#Sec3}
-------------------------------------

3T3L1 cells were kindly donated by María Pardo and Luisa M Seoane (University of Santiago, Spain). Cells were maintained as pre-adipocytes in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 % foetal bovine serum (FBS) and expanded when they reached 70 % confluence.

Cloning procedure {#Sec4}
-----------------

Full-length human PG and green fluorescent protein (GFP) cDNAs were amplified by PCR from pBABE-puroGFP-PG and pBABE-puroGFP-Lamin A plasmids (Addgene, donated by Tom Misteli), using the oligonucleotides: *Eco*RI-LMNA-forward, CCGGAATTCATGGAGACCCCGTCCCAGCGG; *Bam*HI-LMNA-reverse, CGCGGATCCTTACATGATGCTGCAGTTCTG; *Eco*RI-GFP-forward, CCGGAATTCATGGTGAGCAAGGGCGAG; and *Bam*HI-GFP-reverse, CGCGGATCCTTACTTGTACACCTCGTC. GFP, LMNA and PG were cloned into pLVX-puro (Clontech Laboratories Inc., Mountain View, CA, USA) between the *Eco*RI/*Bam*HI sites following standard cloning procedures.

Lentiviral production {#Sec5}
---------------------

The Lenti-X™ Lentiviral expression System (Clontech Laboratories Inc.) was used following the manufacturer's protocol. One day before transfection, 4 × 10^6^ 293 T producer cells were plate on 100 mm plates in penicillin/streptomycin-free DMEM supplemented with 5 % FBS. The following day, two different calcium-phosphate based transfections were performed in duplicate using LVX-GFP-puro and LVX-PG-puro. The cells were incubated overnight with the transfection mixture, then washed with phosphate-buffered saline (PBS) and incubated with 8 ml fresh complete growth medium.

Viral supernatants were collected at 48, 60 and 72 hours following transfection, centrifuged, filtered to remove cell debris and stored at 4 °C until transduction.

Transduction of 3T3L1 cells {#Sec6}
---------------------------

Target cells were plated in 100 mm plates at 6 × 10^6^ cells per plate. After 1 day, the cells were 70 % confluent. The cells were incubated sequentially with the 48-hour, 60-hour and 72-hour viral supernatants for 12 hours. Following the last transduction, the cells were washed and incubated with fresh growth medium to allow puromycin-resistance expression. Two days later, puromycin selection was performed by incubating the cells in growth media supplemented with 1 μg/ml puromycin (Clontech Laboraties Inc.) for 5 days. After selection, transduced cells were washed and allowed to recover in complete media for 2 days.

Proliferation assay {#Sec7}
-------------------

To calculate the proliferation curve, different numbers of cells (0, 1000, 2000, 4000, 8000 and 16,000) were plated in triplicate in 96-well plates and allowed to adhere for 8 hours. The CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay (Promega, Madison, WI, USA) was used to measure absorbance at 490 due to the formation of MTS formazan. For the assay, 2000 cells were plated in triplicate in 96-well plates, and the total cell number was calculated at different time points (2, 4, 6 and 10 days) by extrapolating the correspondent absorbance in the proliferation curve.

Adipogenic differentiation {#Sec8}
--------------------------

Untransduced and PG-transduced and GFP-transduced 3T3L1 pre-adipocytes were differentiated in DMEM supplemented with 10 % FBS in chamber slides (Millipore, Billerica, MA, USA). Two days after reaching confluence, the medium was supplemented with 10 μg/ml insulin, 0.5 mM of 3-isobutyl-1-methylxantine and 1 am dexamethasone for 3 days and with 5 μg/ml insulin for a further 6 days.

Adipogenic cultures were stained with Oil red O to determine their adipogenic capacity. For staining, the culture plates were fixed in 10 mM sodium periodate, 2 % paraformaldehyde, 75 mM [l]{.smallcaps}-lysine dihydrochloride and 37.5 mM dibasic sodium phosphate (Sigma-Aldrich, St. Louis, MO, USA) at pH 7.4 for 15 minutes at room temperature, then air dried and treated with a filtered solution of 0.3 % Oil red O to stain lipid droplets.

Protein extraction and preparation procedures {#Sec9}
---------------------------------------------

Cells monolayers were grown until a confluence of 70 % in 100 mm plates, and then washed three times with PBS and harvested with a scraper in SDS lysis buffer (20 % glycerol, 500 mM Tris--HCl, pH 6.8 and 10 % sodium dodecyl sulphate). After incubation at 100 °C for 10 minutes and two consecutive cycles of vortexing and sonication, samples were centrifuged at 4 °C for 10 minutes at 11000 × g. Supernatants were then subjected to protein quantification (total protein A 280) in a nanodrop™ 1000 instrument (Thermo Scientific, Waltham, MA, USA). Protein extracts were aliquoted and stored at −80 °C until further analysis.

iTRAQ labelling {#Sec10}
---------------

Equal amounts of proteins from PG-3T3L1 and GFP-3T3L1 cells (50 μg) were precipitated with overnight incubation with six volumes of cold acetone at −20 °C, and denatured with 2 % sodium dodecyl sulphate in 1 M triethylammonium bicarbonate (ABSciex, Foster City, CA, USA). The samples were then reduced for 1 hour at 60 °C using 50 mM tris-(2-carboxyethy) phosphine (ABSciex), and cysteine-blocked with 84 mM iodoacetamide (Sigma-Aldrich) at room temperature in the dark for 30 minutes. The injection volumeThe proteins were digested with spectrometry-grade trypsin (Gold Mass, Promega, Madison, WI, USA) at a concentration of 1:50 trypsin/protein for 16 hours at 37 °C. Each peptide solution was labelled for 1.5 hours at room temperature using the iTRAQ reagents (ABSciex) previously reconstituted in 70 μl ethanol, following the manufacturer's protocol. The samples were labelled with iTRAQ reagents as follows: control GFP, 115; PG: 117. The reaction was stopped by adding deionized water, and the labelled samples were combined. The mixture was desalted using homemade stage tips.

iTRAQ relative quantification by two-dimensional LC-MALDI-TOF/TOF analysis {#Sec11}
--------------------------------------------------------------------------

In a first step, the desalted peptides (starting amount of digested peptides: 100 μg) were fractionated by basic reversed-phase extraction in a 1200 HPLC system (Agilent, Wilmington, DE, USA). Sixty fractions, each representing a 90-second elution, were collected along a 110-minute gradient. The fractions were combined in 16 different final fractions depending on their peptide complexity (as revealed by lecture absorbance at 214 nm during the basic reversed-phase separation). The combined fractions were subjected to further acidic reversed-phase extraction in a nanoHPLC system (Tempo; ABSciex) into a C18 silica-based column (New Objective, Woburn, MA, USA) with an internal diameter of 300 Ả. The injection volume was 5 μl, and peptides were eluted during a 90-minute gradient at a constant flow rate of 0.35 μl/minute. Eluting peptides were automatically mixed with alpha-cyano at 4 mg/ml in 70 % acetonitrile, 0.1 % trifluoroacetic acid and deposited on a MALDI LC-plate using a SunCollect (SunChrom, Friedrichsdorf,GE) spotter. The 16 different chromatograms, each composed of 350 spots (15 seconds deposition per spot), were then analysed in a 4800 MALDI-TOF/TOF platform (ABSciex). The 4000 series Explorer v.4.2 software was used to generate the spectra and peak list. After manual deposition of mass calibrants, plate model and default calibration of the MALDI plate was carried out with a laser voltage of 3200 kV and 1000 shots/spectrum. Samples were automatically analysed in MS mode with a laser voltage of 3400 kV and 1500 shots/spectrum.

Automated precursor selection was performed using a Job-wide interpretation method (up to 12 precursors/fraction, signal-to-noise lower threshold = 50) excluding trypsin autolytic peptides and other background ions, with a laser voltage of 4200 and 2000 shots/spectrum. The collision induced dissociation (CID) energy range was medium.

Liquid chromatography coupled offline to matrix-assisted laser desorption ionization--time of flight (LC-MALDI-TOF/TOF) data were analysed using ProteinPilot 4.0 software (ABSciex). ProteinPilot search parameters were as follows: sample type, iTRAQ 4-plex; *cys*-alkylation, iodoacetamide; digestion, trypsin; ID focus, biological modifications; database, NCBI RefSeq-release60 (September 2013) with 41,958,567 entries; species filtering, none; search effort, thorough ID and Detection Protein Threshold Unused ProtScore (Conf) \> 1.3 (95.0 %). The scoring model was defined by the Paragon algorithm. In the case of the high-complexity samples, the false discovery rate was estimated in less than 1 % by doing the searching in parallel against a decoy database using the 'PSPEP on' mode (data not shown).

Bioinformatics {#Sec12}
--------------

Biological functional analysis of the different modulated proteins detected by iTRAQ quantification was categorized according to their function, biological process and cellular component, using the String 9.0 software \[[@CR23]\].

Measurement of the production of mitochondrial reactive oxygen species {#Sec13}
----------------------------------------------------------------------

Cells were cultivated in six-well plates in DMEM with 10 % FBS until reaching 70 % confluence, and then washed and incubated for 1 hour with serum-free DMEM. Incubation with 5 μM MitoSox™ (Invitrogen) was done for 10 minutes at 37 °C following the manufacturer's instructions. Mitochondrial reactive oxygen species (ROS) production was estimated by flow cytometry in a FACSAria instrument (Benton Dickinson, Oxford, UK). The percentage of positive cells was measured for each condition by fluorescent emission at 580 nm.

Measurement of the mitochondrial reespiratory chain complex activities {#Sec14}
----------------------------------------------------------------------

For each condition 10 × 10^6^ cells were collected by trypsinization, washed with PBS, and precipitated at 150 × *g* for 5 minutes at 4 °C. Digitonin-permeabilized pre-adipocyte homogenates (10--50 μl/ml test volume) were used to measure the activities of the respiratory chain enzymes and citrate synthase in a DU-650 spectrophotometer (Beckman Instruments, Palo Alto, CA, USA) as described previously \[[@CR24], [@CR25]\].

Determination of basal mitochondrial respiration {#Sec15}
------------------------------------------------

The rate of oxygen consumption (OCR) was determined by direct measurement in a SeaHorse XFp Extracellular Flux Analyzer instrument (Seahorse Bioscience Inc., Billerica, MA, USA). Then 10^4^ cells per well were seeded 24 hours prior to the assay in XF cell culture microplates and incubated at 37 °C with 5 % CO~2~. The next day, the cells were pre-incubated without CO~2~ for 1 hour and the basal OCR was determined following the manufacturer's instructions.

Immunoblotting procedures {#Sec16}
-------------------------

Western blot analysis was performed on 20 μg total protein extracted from cells in culture, as described previously \[[@CR26]\]. The antibodies used were mouse Lamin A + C (Acris Antibodies, Acris Antibodies, Barcelone,ES), rabbit calnexin (Santa Cruz Biotech., Santa Cruz, CA, USA), rabbit nucleolin (NCL; Santa Cruz Biotech.), rabbit cytochrome c oxidase (Amersham, Buckinghamshire, UK), rabbit microtubule-associated protein 1 light chain 3 (LC3; MBL, Nagoya, Japan) and mouse tubulin (Sigma). Ideal concentrations for each antibody were determined empirically. Working concentrations were 1:1000 of the stock solutions. Secondary anti-mouse and anti-rabbit antibodies (Amersham) were used to visualize proteins by the ECL™ Western Blotting Analysis System (GE Healthcare, Amersham Biotechnology, Buckinghamshire, UK). Optimal concentrations for each antibody were determined empirically. Blots were digitized using the LAS 3000 image analyser (GE Healthcare). Densitometry analysis of the band intensities was performed using ImageQuant 5.2 software (GE Healthcare).

RNA extraction and cDNA synthesis {#Sec17}
---------------------------------

Total RNA was extracted from cultured cells seeded in six-well plates at a confluence of 70 % using the Trizol L.S. reagent method (Invitrogen). Reverse transcription was done using the Superscript II system (Invitrogen). Then 2 μg total RNA was reverse transcribed in a 20 μl reaction volume containing Superscript II (200 Units), random primers (25 μM) and dNTP (0.5 mM each) at 42 °C for 50 minutes.

Real-time RT-PCR analysis {#Sec18}
-------------------------

The reported sequences of genes for mouse Lmna (forward, TGAGTACAACCTGCGCTCAC; reverse, CTGTGACACTGGAGGGCAGAA), mouse Ncl (forward, AAGGAGTGAAGCCAGCAAAA; reverse, TCCTCCTCAGCCACACTCTT), mouse Canx (forward, GCCCTAGAGACTGCTCCAT; reverse, AAAAAGCCTTGTGCTCCACA), mouse Cox5a (forward, GGAATTGCGTAAAGGGATGA; reverse, CCAAGATGCGAAGACCACTA) and mouse Hprt (forward, TCCCAGCGTCGTGATTAGCGA; reverse, TGGCCTCCCATCTCCTTCATGAC), as housekeeping, were used for primer design. The amplification program consisted of an initial denaturation at 92 °C for 2 minutes followed by 40 cycles at 92 °C for 15 seconds, annealing at 61 °C for 30 seconds and an extension at 72 °C for 15 seconds. Each PCR analysis was done in duplicate, with each set of assays repeated three times. To minimize effects of unequal quantities of starting RNA and to eliminate potential sources of inconsistency, relative expression levels of each gene were normalized to Hprt using the 2^--ΔΔCt^ method \[[@CR27]\]. Control experiments contained no reverse transcriptase.

Statistical analysis {#Sec19}
--------------------

All of the experimental data, with the exception of the iTRAQ relative quantification, are presented as the mean, and error bars represent the standard deviation of the mean. Statistical analysis was carried out with R 3.0 (Project for Statistical Computing) using non-parametric methods.

Results {#Sec20}
=======

Gene delivery by lentiviral transduction and characterization of cell lines {#Sec21}
---------------------------------------------------------------------------

Efficient gene delivery of PG was checked by immunoblotting using an anti-LMNA/C antibody. As shown in Fig. [1a](#Fig1){ref-type="fig"}, PG-lentiviral transduction of 3T3L1 pre-adipocytes drives the production of an intermediate molecular weight isoform with a similar size as human PG, as well as an abnormal accumulation of wild-type Lamin A as described previously \[[@CR28], [@CR29]\]. The efficiency of the transduction was estimated in more than 80 % by fluorescence microscopy. Proliferation capacity was checked in the three cell lines, showing a significant decrease (*p* \<0.05) in the proliferation rate of PG-3T3L1 cells when compared with non-transduced and control GFP-3T3L1 cells. Adipogenic capacity of the cell lines was tested by directed differentiation in adipogenic medium for 7 days followed by Oil red staining and haematoxylin and eosin counterstaining (Fig. [1c](#Fig1){ref-type="fig"}). PG-3T3L1 cells show a defective adipogenic capacity when compared with non-transduced and control GFP-3T3L1 cells. Oil red densitometry demonstrates a significant (*p* \<0.05) decrease in the total area of the lipid droplets (Fig. [1c](#Fig1){ref-type="fig"}).Fig. 1Characterization of green fluorescent protein (GFP)-expressing and progerin (PG)-expressing 3T3L1 cells. **a** Efficient gene delivery of PG and GFP was corroborated by immunoblot and fluorescence microscopy, respectively. **b** Decrease in the proliferation rate of PG-3T3L1 cells when compared with GFP-3T3L1 and non-transduced cells. **c** Defective adipogenic potential of PG-3T3L1 cells when compared with GFP-3T3L1 and non-transduced cells, as revealed by Oil-red staining. \*Significance (*p* \<0.05) using the Kruskal--Wallis non-parametric test. Scale bar = 20 μm

iTRAQ relative quantification {#Sec22}
-----------------------------

A summary of the workflow followed for iTRAQ relative quantification of modulated proteins in PG-3T3L1 cells versus GFP-3T3L1 cells is shown in Fig. [2a](#Fig2){ref-type="fig"}. A total of 1633 proteins were identified after grouping; 76 of them were significantly decreased whereas 105 were increased in PG-3T3L1 versus control (Fig. [2b](#Fig2){ref-type="fig"}). Proteins were considered significantly modulated if the 117/115 ratio was higher than 1.4 or lower than 0.7, always with *p* \<0.05. Only proteins presenting similar significant ratios in both iTRAQ experiments 1 and 2 were considered modulated. The detailed list of modulated proteins classified by principal biological process is presented in Table [1](#Tab1){ref-type="table"}.Fig. 2Isobaric tags for relative quantification (iTRAQ) of modulated proteins in 3T3L1-PG cells. **a** Workflow followed for the relative quantification of modulated proteins in PG-3T3L1 cells. **b** Summary of the protein identification and relative quantification. **c** Significantly modulated biological processes after String 9.0 analysis of the modulated individual proteins. *GFP* green fluorescent protein, *GO* gene ontology, *LC-MALDI-TOF* liquid chromatography coupled offline to matrix-assisted laser desorption ionization--time of flight, *PG* progerinTable 1Modulated proteins (*p* \<0.05) in PG-3T3L1 cells classified according to their principal biological processAccession numberNameTotal number of peptidesiTRAQ 1 ratio PG/controliTRAQ 2 ratio PG/controlActin cytoskeleton organization gi\|157951604Adenylyl cyclase-associated protein 191.801.81 gi\|6680924cofilin-1222.632.63 gi\|6681069Cysteine and glycine-rich protein 190.410.44 gi\|62526118Cytoskeleton-associated protein 4226.025.81 gi\|125347376Filamin-A1230.060.06 gi\|145966915Filamin-B890.180.22 gi\|124487139Filamin-C510.420.44 gi\|130488506Four and a half LIM domains protein 380.390.34 gi\|61657921Kinesin-1 heavy chain140.490.44 gi\|6755040Profilin-1192.902.94 gi\|10946578Thymosin beta-4150.420.44 gi\|47894398Tropomyosin alpha-4 chain510.570.60 gi\|31982755Vimentin10127.829.5Alternative splicing gi\|85060507Heterogeneous nuclear ribonucleoprotein A1276.948.24 gi\|21313308Heterogeneous nuclear ribonucleoprotein M172.702.85 gi\|283436178Heterogeneous nuclear ribonucleoproteins C1/C2101.821.85 gi\|6678143Lupus La protein homolog91.571.89 gi\|31560656Polyadenylate-binding protein 1241.551.88 gi\|126157504Serine/arginine repetitive matrix protein 2120.330.35 gi\|34328400Serine/arginine-rich splicing factor 1 isoform 1120.580.63 gi\|153791358Splicing factor 3B subunit 170.500.52 gi\|268837785Splicing factor 3b, subunit 2161.591.62 gi\|23956214Splicing factor, proline- and glutamine-rich221.481.45ATP metabolism gi\|6680748ATP synthase subunit alpha212.532.48 gi\|31980648ATP synthase subunit beta325.895,84 gi\|7949005ATP synthase-coupling factor 680.350.38 gi\|150456419ATP-dependent RNA helicase A100.520.45 gi\|134288917Cytoplasmic dynein 1 heavy chain 1160.480.53Calcium-mediated signalling gi\|6996913Annexin A2281.891.72 gi\|6753060Annexin A5266.016.47 gi\|21704156Caldesmon 1312.172.49 gi\|6753244Calmodulin220.310.31 gi\|6671664Calnexin141.622.44 gi\|21312564Calponin-3152.011.79 gi\|6680836Calreticulin precursor313.373,98 gi\|31981086EF-hand domain-containing protein D260.390.40 gi\|6679465Glucosidase 2 subunit beta precursor90.590.69 gi\|33620739Myosin light polypeptide 6240.690.39 gi\|6677833Protein S100-A10110.280.31 gi\|6677691Reticulocalbin-1 precursor100.500.69 gi\|114205428Reticulocalbin-2 precursor120.480.45 gi\|188035858Reticulocalbin-3 precursor130.410.54 gi\|295054266Spectrin alpha chain, brain isoform 2800.600.58 gi\|117938332Spectrin beta chain, brain 1 isoform 1450.500.43Cell adhesion gi\|61743961AHNAK nucleoprotein isoform 12650.630.62 gi\|6754508LIM and SH3 domain protein 1150.550.59 gi\|225543161Lipoma-preferred partner homolog isoform 1180.550.55 gi\|70778915Moesin413.312.80 gi\|33598964Myosin-10420.180.19 gi\|114326446Myosin-9 isoform 11270.050.04 gi\|254675244Plectin isoform 11510.310.56 gi\|377835925Protein AHNAK2-like160.780.54 gi\|227116327Talin-1420.250.24 gi\|6678347Thy-1 membrane glycoprotein preproprotein54.153.93 gi\|6756085Zyxin190.520.55 gi\|114326497Laminin subunit beta-150.340.37 gi\|31982030Rho GDP-dissociation inhibitor 1102.602.49DNA replication gi\|6679299Prohibitin91.822.39 gi\|7242171Proliferating cell nuclear antigen101.731.78Extracellular matrix organization gi\|34328108Collagen alpha-1(I) chain precursor560.660.49 gi\|111120329Collagen alpha-2(I) chain precursor530.670.68 gi\|33859580Galectin-3121.961.81 gi\|33859596Prolyl 4-hydroxylase subunit alpha-1 precursor141.891.89Glycolysis gi\|6679937Glyceraldehyde-3-phosphate dehydrogenase3325.523.1 gi\|70778976Phosphoglycerate kinase 1403.373.18 gi\|226958349Triosephosphate isomerase202.582.53 gi\|70794816Alpha enolase5516.820.2Golgi apparatus function gi\|254750698Nucleobindin-1 isoform 1 precursor170.530.54 gi\|194440700Nucleobindin-2 isoform 1 precursor50.530.54Lipid metabolism gi\|6681137Acyl-CoA-binding protein isoform 2100.290.29 gi\|63999380Alpha-2-macroglobulin receptor-associated40.400.42 gi\|313151222ATP-citrate synthase isoform 1100.460.53 gi\|93102409Fatty acid synthase80.550.55 gi\|225735657Sulphated glycoprotein 1 isoform F preproprotein95.495.24Lipid transport gi\|19527028Vigilin151.521.47 gi\|38198665NSFL1 cofactor p47130.690.64Nuclear structure gi\|162287370Prelamin-A/C isoform A474.624.79 gi\|7110705Prothymosin alpha70.420.43Nucleosome assembly gi\|7949045Histone H2A.Z61.731.49 gi\|13591862Protein SET isoform 1210.220.27Nucleotide biosynthesis gi\|209862992Dihydropyrimidinase-related protein 3 isoform 1181.951.75 gi\|377835587inosine-5′-monophosphate dehydrogenase 2-like91.471.68Oxidation--reduction process gi\|31542438Cytochrome b5 type B precursor63.053.20 gi\|112181182Cytochrome c oxidase subunit 5A120.350.28 gi\|6681095Cytochrome c, somatic90.440.41 gi\|112293264Protein disulphide-isomerase A3 precursor496.035.80 gi\|86198316Protein disulphide-isomerase A4 precursor271.551.61 gi\|42415475Protein disulphide-isomerase precursor441.861.87 gi\|6755911Thioredoxin100.470.47Protein catabolic process gi\|667950126S protease regulatory subunit 4152.212.59 gi\|22800833726S protease regulatory subunit 6A161.971.93 gi\|12424857726S protease regulatory subunit 6B122.272.37 gi\|1988220126S proteasome non-ATPase regulatory subunit90.540.52 gi\|6755212Proteasome activator complex subunit 1120.600.58Protein folding and stress response gi\|668030910 kDa heat shock protein, mitochondrial80.340.34 gi\|18339677160 kDa heat shock protein, mitochondrial4623.913.9 gi\|115270960BAG family molecular chaperone regulator 390.570.59 gi\|6755863Endoplasmin precursor426.427.51 gi\|31981690Heat shock cognate 71 kDa protein6814.419.9 gi\|6754254Heat shock protein HSP 90-alpha442.222.26 gi\|40556608Heat shock protein HSP 90-beta482.552.46 gi\|27229055Huntingtin-interacting protein K50.400.42 gi\|161353506Serpin H1 precursor222.442.39 gi\|162461907Stress-70 protein, mitochondrial522.052.04 gi\|126521835T-complex protein 1 subunit beta181.711.68 gi\|6671702T-complex protein 1 subunit epsilon161.591.51 gi\|6753324T-complex protein 1 subunit zeta111.661.75Protein transport gi\|28077049Charged multivesicular body protein 4b90.510.51 gi\|51491845Clathrin heavy chain 1180.520.48 gi\|122939198Clathrin light chain A isoform c70.440.45 gi\|88014720Importin subunit beta-190.410.42 gi\|124486712Ribosome-binding protein 1 isoform a200.600.65Regulation of apoptosis and cell death gi\|22687490614-3-3 protein epsilon132.011.62 gi\|675604114-3-3 protein zeta/delta isoform 1152.552.61 gi\|6678682Galectin-1310.700.59 gi\|329755243Gelsolin isoform 2221.851.89 gi\|165932375Plasminogen activator-inhibitor 1 RNA-binding protein310.670.68 gi\|9790259Programmed cell death protein 580.490.35 gi\|6755963Voltage-dependent anion-selective channel protein 1152.532.41Regulation of canonical Wnt signalling gi\|6679641Emerin82.873.42 gi\|7305075ras GTPase-activating protein-binding protein 1162.251.99 gi\|158854016S-phase kinase-associated protein 170.500.50Regulation of cell proliferation gi\|124517663Annexin A1282.441.88 gi\|110625813Astrocyte-derived neurotrophic factor precursor110.470.47 gi\|28461294Protein CDV3 isoform b80.520.57 gi\|356640163Serine hydroxymethyltransferase, mitochondrial171.901.72 gi\|6678483Ubiquitin-like modifier-activating enzyme 1150.590.58Transcription gi\|188497724Hepatoma-derived growth factor120.550.50 gi\|84875537Nucleolin333.604.17 gi\|6679567Polymerase I and transcript release factor172.232.65 gi\|13386026UPF0568 protein C14orf166 homolog90.600.60Translation and ribosome assembly gi\|30926624160S ribosomal protein L29-like41.901.90 gi\|30926351160S ribosomal protein L32-like67.279.17 gi\|2142688940S ribosomal protein S11112.992.84 gi\|1338603440S ribosomal protein S13104.746.81 gi\|667779940S ribosomal protein S15112.261.82 gi\|1296351140S ribosomal protein S19102.923.02 gi\|1808780540S ribosomal protein S2142.752.88 gi\|1319560440S ribosomal protein S2375.354.83 gi\|675537240S ribosomal protein S3161.641.65 gi\|25455332140S ribosomal protein S3a132.752.65 gi\|667780540S ribosomal protein S4, X isoform147.604.25 gi\|667781340S ribosomal protein S8125.305.39 gi\|3350448340S ribosomal protein S9114.414.01 gi\|667156960S acidic ribosomal protein P0101.401.56 gi\|8374512060S acidic ribosomal protein P2140.310.30 gi\|1641833960S ribosomal protein L10113.043.81 gi\|3198194560S ribosomal protein L13a93.963.00 gi\|1338503660S ribosomal protein L1574.403.52 gi\|8369942460S ribosomal protein L1853.033.22 gi\|5803746560S ribosomal protein L18a62.992.92 gi\|22695865760S ribosomal protein L19 isoform 274.354.19 gi\|1825029660S ribosomal protein L2464.454.11 gi\|667777760S ribosomal protein L2673.803.31 gi\|856740060S ribosomal protein L2795.655.99 gi\|25530889960S ribosomal protein L3203.473.23 gi\|9438622460S ribosomal protein L36-like49.038.15 gi\|3079445060S ribosomal protein L4205.755.20 gi\|2395608260S ribosomal protein L5102.041.32 gi\|8466273660S ribosomal protein L6117.248.24 gi\|3198151560S ribosomal protein L795.656.23 gi\|730544360S ribosomal protein L7a96.306.42 gi\|675535860S ribosomal protein L878.876.51 gi\|1414964760S ribosomal protein L991.812.29 gi\|25454016878 kDa glucose-regulated protein precursor495.204.12 gi\|82617575Bifunctional glutamate/proline\--tRNA ligase60.430.44 gi\|126032329Elongation factor 1-alpha 1332.482.63 gi\|31980922Elongation factor 1-beta160.390.30 gi\|33859482Elongation factor 2440.320.50 gi\|21450625Eukaryotic initiation factor 4A-I isoform 1232.291.96 gi\|146219837Eukaryotic translation initiation factor 3190.500.63 gi\|365906249Eukaryotic translation initiation factor 380.490.32 gi\|167234372Eukaryotic translation initiation factor 4B230.590.60 gi\|31712036Eukaryotic translation initiation factor 5A-1260.530.54 gi\|9436703840S ribosomal protein S6-like isoform 265.495.50 gi\|30926402240S ribosomal protein SA-like163.024.32 gi\|14925117760S ribosomal protein L13-like84.113.18 gi\|37783725860S ribosomal protein L23-like83.833.84 gi\|6357217260S ribosomal protein L27a-like46.995.21 gi\|37497112Putative RNA-binding protein 3 isoform 180.590.55 gi\|31982373rRNA 2′-O-methyltransferase fibrillarin82.152.07*iTRAQ* isobaric tags for relative quantification, *PG* progerin

The list of modulated proteins was used to unravel, by String 9.0 analysis, the molecular pathways altered in PG-3T3L1 cells (Fig. [2c](#Fig2){ref-type="fig"}). Among the most important processes determined are those related to translation (gene ontology (GO) process: 0006412), ribosome biogenesis (GO process: 0042273) and protein folding (GO process: 0006457), but also metabolism (GO process: 0008152), energy generation by the mitochondria (GO process: 0006754) and structure of the actin cytoskeleton (GO process: 0030036).

Immunoblotting and real-time PCR validation of selected modulated proteins {#Sec23}
--------------------------------------------------------------------------

Orthogonal validation of iTRAQ results by western blotting (Fig. [3](#Fig3){ref-type="fig"}) demonstrated in the first place that Lamin A (ratio PG/control = 4.69) is actually accumulated in PG-3T3L1. Besides, immunoblotting of NCL and calnexin, both accumulated in PG-3T3L1, show similar densitometry ratios (4.40 and 2.60) to those obtained by iTRAQ quantification (3.83 and 1.84, respectively). Finally, cytochrome c is decreased in PG-3T3L1 cells with a similar densitometry ratio (0.41) to that obtained by iTRAQ quantification (0.43). Real-time PCR data are in concordance with the proteomics data, with the exception of cytochrome c. This gene is overexpressed in PG-3T3L1 cells when compared with control.Fig. 3Immunoblotting and RT-PCR verification of selected proteins. **a** Western blotting analysis confirms the modulation of Lamin A, calnexin (CALX), nucleolin (NCL), and cytochrome c (CYC). Loading of equal amount of total protein was tested by Ponceau red staining (not shown) and α-tubulin immunoblotting. **b** Real-time PCR analysis of the selected proteins normalized against Hprt gene levels. \*Significance (*p* \<0.05) using the Kruskal--Wallis non-parametric test. \*\*Significance (*p* \<0.01) using the Kruskal--Wallis non-parametric test. *iTRAQ* isobaric tags for relative quantification, *PG* progerin

Study of the mitochondrial function in PG-3T3L1 cells {#Sec24}
-----------------------------------------------------

Since iTRAQ data suggest a dysfunction of the mitochondrial activity and a disorganization of the nuclear--mitochondrial cytoskeleton network we decided to determine the integrity of the mitochondrial network in PG-3T3L1 cells. First spectrophotometric analysis of the mitochondrial respiratory chain demonstrates significant differences in the activity of electron carrier complex I, IV and V (Fig. [4a](#Fig4){ref-type="fig"}). The mitochondrial superoxide anion was determined by flow-cytometry measurement of MitoSox™-treated cells, revealing that PG-expressing cells show a significant (*p* \<0.05) increase in superoxide anion production (Fig. [4b](#Fig4){ref-type="fig"}). Furthermore, the OCR, a parameter that is proportional to mitochondrial basal activity, is also significantly (*p* \<0.001) increased in PG-3T3L1 cells (Fig. [4c](#Fig4){ref-type="fig"}).Fig. 4Mitochondrial dysfunction and ROS overproduction in 3T3L1-PG cells. **a** Measurement of the mitochondrial complex activity in digitonin-permeabilized cells demonstrates significant changes in complexes I, IV and V. **b** PG-3T3L1 cells show a significant increase in the mitochondrial ROS production, as revealed by MitoSox™ analysis. **c** Measurement of the rate of oxygen consumption (OCR) indicates that PG-3T3L1 cells have an increased mitochondrial basal activity. \*Significance (*p* \<0.05) using the Kruskal--Wallis non-parametric test. \*\*\*Significance (*p* \<0.001) using the Kruskal--Wallis non-parametric test. Scale bar = 10 μm. *CS* citrate synthase, *PG* progerin

Reduction of ROS levels with ROS scavengers and the effect of autophagy {#Sec25}
-----------------------------------------------------------------------

Incubation of PG-3T3L1 with a general ROS scavenger (*N*-acetyl-cysteine (NAC) 10 mM for 1 hour; Fig. [5a](#Fig5){ref-type="fig"}, [b](#Fig5){ref-type="fig"}) or a superoxide-specific quencher (MitoTempo 10 μM for 1 hour; Fig. [5c](#Fig5){ref-type="fig"}, [d](#Fig5){ref-type="fig"}) results in a significant (*p* \<0.05) reduction of the autophagic marker LC3-II/LC3-I ratio, indicating a decrease in autophagic proteolysis.Fig. 5Effect of ROS scavengers on the autophagic proteolysis in PG-3T3L1 cells. **a**, **b** Western blot analysis of LC3 demonstrates a significant reduction in the LC3-II/LC3-I ratio in PG-3T3L1 cells incubated with 10 mM *N*-acetyl-cysteine (NAC) for 1 hour when compared with basal conditions. **c**, **d** Western-blot analysis of LC3 demonstrates a significant reduction in the LC3-II/LC3-I ratio in PG-3T3L1 cells incubated with 10 μM MitoTempo for 1 hour when compared with basal conditions. *LC3* light chain 3, *PG* progerin

Discussion {#Sec26}
==========

Aging is defined as the accumulation of diverse deleterious changes occurring in cells and tissues with advancing age that are responsible for the increased risk of disease and death \[[@CR30]\]. Aging is now considered to be a very complex, multi-factorial process \[[@CR31]\]. Several aging theories have been proposed, but to date no single theory explains all of the major age-related physiological changes. Among those theories, the role of mitochondrial dysfunction and free radical accumulation in aging and disease has gained strength in recent years \[[@CR32]--[@CR35]\], in part owing to the satisfactory effects exerted by antioxidant compounds in in-vitro studies \[[@CR36]\] and therapy \[[@CR37]--[@CR39]\].

Premature aging syndromes are used as models to understand molecular causes of aging-related changes. Among these diseases, HGPS is one of the most studied, although to date few proteomics studies have tried to deep into the mechanisms triggered by the accumulation of the causal agent (PG). Peinado et al. \[[@CR40]\] demonstrated using a differential in gel electrophoresis (DIGE) approach that mitochondrial dysfunction and disorganization of the cytoskeleton were characteristic of the adipose tissue in *ZMPSTE24* null mice, which mimic some but not all of the symptoms associated with HGPS-derived cells. Recently, similar results have been found in HGPS cells \[[@CR41]\] following a stable isotopic labeling approach. To examine by quantitative proteomics (iTRAQ) the effect of the impairment of the expression of Lamin A, we used a lentiviral system to efficiently deliver PG expression in 3T3L1 pre-adipocytes. The efficient expression of PG in PG-transduced 3T3L1 cells was corroborated by immunoblotting (Fig. [1a](#Fig1){ref-type="fig"}). These cells present a decrease in both proliferative capacity and adipogenic potential (Fig. [1b](#Fig1){ref-type="fig"}, [c](#Fig1){ref-type="fig"}), which is in agreement with previous results \[[@CR29]\]. Since GFP-3T3L1 cells are similar to non-transduced 3T3L1 in terms of lamin expression, adipogenic capacity and proliferative rate, we decided to use that cell line as a control for the iTRAQ labelling and subsequent validations. A total of 1633 different proteins were quantified, and 181 of them were significantly modulated in PG-expressing cells versus control. To our knowledge, our study represents the first iTRAQ-based proteomic analysis on the effect of PG expression to date.

Quantitative proteomics data suggest massive modulation of cytoskeleton organization, cell proliferation and protein synthesis processes {#Sec27}
----------------------------------------------------------------------------------------------------------------------------------------

String 9.0 analysis demonstrate that expression of PG in 3T3L1 cells promotes changes in protein translation, energy generation by mitochondria, protein folding, response to stress, lipid metabolism and cytoskeleton organization.

Expression of PG in 3T3L1 cells promotes modulation of a large set of regulators and structural components of the cytoskeleton, mainly those involved in the proper maintenance of the filamentous network connecting nucleus, endoplasmic reticulum and mitochondria. Of special interest we have detected upregulation of vimentin (ratio PG/control = 27.28) and cytoskeleton-associated protein 4 (ratio PG/control = 5.9), and downregulation of filamins A (ratio PG/control = 0.06), B (ratio PG/control = 0.18) and C (ratio PG/control = 0.43). Modulation of vimentin has been described previously in Zmpste24^−/−^ mice \[[@CR40]\] and HGPS-derived cell lines \[[@CR41]\].

Calcium ions are signalling molecules in living cells and play essential roles in cellular processes such as cell proliferation, enzyme activity, muscle contraction, cellular motility, maintenance of the structural integrity of the cytoskeleton and membrane transport, among others \[[@CR42]\]. Our proteomics data show modulation of a set of proteins involved in calcium-mediated signalling, including calmodulin (ratio PG/control = 0.31), caldesmon 1 (ratio PG/control = 2.29), calnexin (ratio PG/control = 1.83) and calreticulin ratio (PG/control = 3.73). Of special interest, calnexin is part of the quality control machinery that holds back improperly folded proteins in the endoplasmic reticulum \[[@CR43]\]. Western blot and real-time PCR validation (Fig. [3](#Fig3){ref-type="fig"}) confirms the increase of calnexin in PG-3T3L1 cells, suggesting that protein misfolding is enhanced by PG expression, a phenomenon described previously in biological \[[@CR44], [@CR45]\] and PG-related \[[@CR46]\] aging.

It is now widely accepted that PG accumulation modulates molecular pathways such as mTOR, pRB and Wnt signalling cascades, driving alterations in the balance between apoptosis, cell differentiation and cell proliferation \[[@CR8], [@CR9], [@CR47]\]. In our model we have detected modulation of proteins belonging to those three processes. For instance, voltage-dependent anion-selective channel protein 1, involved in the formation of apoptotic pores in the mitochondria \[[@CR48]\], is upregulated in PG-3T3L1 cells (ratio PG/control = 2.53), as well as emerin (ratio PG/control = 3.31). This protein interacts with LAP2α and links nuclear Lamin A and actin cytoskeleton, negatively modulating accumulation of beta-catenin in the nucleus \[[@CR49], [@CR50]\].

Proteomic data strongly suggest a massive modulation of all molecular processes that culminate in protein synthesis and function. Of special interest is the modulation detected on NCL, the major component of the nucleolus and a repressor of the transcription \[[@CR51]\]. This protein is upregulated in PG-expressing 3T3L1 cells (ratio PG/control = 3.84). Western blot validation confirms the quantitative proteomics result, as well as real-time PCR analysis. Interestingly, NCL associates with chromatin and is a nucleolar marker of several pathological conditions, ranging from cancer to autoimmune diseases \[[@CR52]\]. Protein SET, which mediates histone acetylation and nucleosome assembly, appears dramatically decreased in PG-expressing cells (ratio PG/control = 0.24). Also, a large set of structural ribosomal proteins and translation initiation factors appear to be modulated in our proteomic screening, in agreement with previous data from Rivera-Torres et al. \[[@CR41]\], indicating that PG expression exerts a dramatic alteration in protein synthesis and function.

Quantitative proteomic data suggest that PG delivery induces defects on de-novo lipid synthesis and energy storage. Three main proteins are decreased in PG-3T3L1 cells. ATP-citrate synthase (ratio PG/control =0.49), fatty acid synthase (ratio PG/control = 0.55) and acyl-CoA-binding protein (ratio PG/control =0.29). All of them are part of the cellular machinery responsible for the condensation of acetyl CoA and malonyl CoA and the formation of medium and long-chain fatty acids and triacylglycerides that are the main energy repository in the cells \[[@CR53]\]. Furthermore, inhibition of ATP-citrate synthase has been recently linked to a decrease in proliferation rate \[[@CR54]\], which has been detected in our model (Fig. [1](#Fig1){ref-type="fig"}) and is a typical characteristic of PG-expressing cells. Our data agree with previous results from other PG-expression models \[[@CR28], [@CR40]\].

Mitochondrial dysfunction and imbalance in stress response are linked to loss of proteostasis and increase of autophagy in progerin-expressing cells {#Sec28}
----------------------------------------------------------------------------------------------------------------------------------------------------

Since energy storage and lipogenesis are modulated in our model of PG overexpression, it is plausible, a priori, to assume that ATP generation by the mitochondria and oxidation--reduction processes could be also affected. iTRAQ analysis demonstrated modulation of several components of the mitochondrial respiratory chain, especially complex IV and complex V. The complex III--complex IV electron carrier cytochrome c (ratio PG/control = 0.43) and the complex IV component cytochrome c oxidase (ratio PG/control = 0.32) are significantly decreased in PG-3T3L1 cells. Cytochrome c decrease has been validated by immunoblotting (Fig. [3](#Fig3){ref-type="fig"}) and is in agreement with previous results \[[@CR41]\]. However, real-time PCR analysis of cytochrome c shows an increase in the expression of this gene in PG-3T3L1 cells.

We asked whether this modulation of several components of the mitochondrial respiratory chain detected in PG-3T3L1 cells by quantitative proteomics drives uncoupling of the electron transport chain. Measurement of the MRC complex activities demonstrates significant differences in the activity of complex IV and V, which agrees with previous results \[[@CR41]\], but also complex I (Fig. [5a](#Fig5){ref-type="fig"}). The activity of this complex is twice as high in PG-3T3L1 when compared with control. Complex I is the main contributor for the generation of mitochondrial ROS and specifically the superoxide anion \[[@CR55], [@CR56]\], which has been proposed as one of the factors responsible for several mitochondrial pathologies \[[@CR57]\] and plays a central role in the free radical theory of aging \[[@CR31]\]. We have found a significantly overproduction of mitochondrial superoxide production in PG-3T3L1 cells, as revealed by MitoSox measurement (Fig. [4b](#Fig4){ref-type="fig"}).

Heat shock proteins (hsp) and chaperones are responsible for monitoring the quality of the proteins, to maintain the homeostasis of the proteome (proteostasis) and to derive incorrect isoforms for ATP-dependent degradation by the proteasome, and are upregulated in living cells in response to environmental stress conditions. We have found a dramatic increase of this group of proteins in PG-3T3L1 cells, indicating an activation of chaperone-mediated autophagy (CMA), a process recently described in age-related pathologies \[[@CR58], [@CR59]\]. The most obvious examples are hsp60 (ratio PG/control = 18.53), heat shock cognate 71 kDa protein (ratio PG/control =16.59) and endoplasmin or GRP94 (ratio PG/control =6.91). Hsp60 is one of the central components that regulate proteostasis during redox imbalance \[[@CR60]\], and is upregulated in stress and disease. Heat shock cognate 71 kDa protein acts as a repressor at the transcriptional level \[[@CR61]\]. Finally, GRP94 is a marker of endoplasmic reticulum-mediated degradation of proteins and has been recently involved in regulation of the canonical *Wnt* signalling pathway \[[@CR62]\]. The loss of proteostasis could explain the apparent discordance between the proteomics and genomics data for cytochrome c. The elevated levels of mitochondrial ROS could promote an increase in the misfolding of the components of the respiratory chain, driving an abnormal rate of protein degradation. In any case, further investigation is necessary to demonstrate this hypothesis.

Previously, an increase in autophagic proteolysis has been reported in the progeroid phenotype \[[@CR63], [@CR64]\], suggesting that chronic activation of an, a priori, pro-survival cellular mechanism can turn into a harmful and detrimental process. We therefore asked whether a reduction of ROS cellular levels could promote a modulation of this process. Incubation of the PG-3T3L1 cells with a general ROS scavenger (NAC 10 mM) or a superoxide anion-specific scavenger (MitoTempo 10 μM) exerts a significant (*p* \<0.05) reduction of the LC3-II/LC3-I ratio (Fig. [5](#Fig5){ref-type="fig"}), pointing to a reduction in the autophagic proteolysis in accordance with the growing evidence supporting the key role of ROS in the aging process.

Conclusions {#Sec29}
===========

Our study represents one further step in the achievement of understanding the aging process. With our results, but also taking into account the results of excellent studies made by other research groups in recent years, we have tried to build a global scheme with a compilation of the main cellular events that leads to premature aging in HGPS driven by PG accumulation (Fig. [6](#Fig6){ref-type="fig"}). In the present work, we have demonstrated that PG expression promotes mitochondrial dysfunction and ROS overproduction. These events are, at least in part, the cause of an increase in protein misfolding and autophagic proteolysis leading, ultimately, to a global loss of proteostasis that partially contributes to the premature aging process. We have also demonstrated that treatment of the cells with antioxidant compounds reduces the autophagic phenotype, thus supporting the growing evidence indicating the importance of this kind of compound as candidates for therapeutics in aging-related diseases.Fig. 6Model representing the main cellular events triggered by lentiviral-driven PG nuclear accumulation and their contribution to the premature aging. PG accumulation leads to modulation of mTOR and WnT pathways, alteration in the protein synthesis machinery and mitochondrial dysfunction and reactive oxygen species (ROS) overproduction, ultimately contributing to the premature aging phenotype
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